Kidney TransplantationTransplantation, HomologousGraft SurvivalGraft RejectionImmunosuppressive AgentsLiver TransplantationTime FactorsBone Marrow TransplantationHematopoietic Stem Cell TransplantationHeart TransplantationTransplantation, AutologousLung TransplantationStem Cell TransplantationTransplantation ConditioningOrgan TransplantationPancreas TransplantationIslets of Langerhans TransplantationTissue DonorsTransplantationTransplantation ImmunologyCell TransplantationTransplantation ChimeraGraft vs Host DiseaseTransplantation, IsogeneicTreatment OutcomeLiving DonorsTransplantation, HeterotopicCord Blood Stem Cell TransplantationPost and Core TechniqueHeart-Lung TransplantationTissue and Organ ProcurementTransplantation TolerancePeripheral Blood Stem Cell TransplantationRetrospective StudiesLiver FailureImmunosuppressionHistocompatibility TestingFetal Tissue TransplantationPostoperative ComplicationsSkin TransplantationRecurrenceWaiting ListsTransplantation, HeterologousMesenchymal Stem Cell TransplantationCorneal TransplantationHistocompatibilityHematologic NeoplasmsTacrolimusTissue TransplantationFollow-Up StudiesCyclosporineWhole-Body IrradiationCadaverSurvival AnalysisSurvival RateBrain Tissue TransplantationFacial TransplantationDonor SelectionLiver DiseasesOrgan PreservationBusulfanTransplantsKidney Failure, ChronicHLA AntigensLeukemiaRisk FactorsCombined Modality TherapyBronchiolitis ObliteransAntilymphocyte SerumPostoperative PeriodAcute DiseaseAnemia, AplasticRemission InductionCytomegalovirus InfectionsMycophenolic AcidHand TransplantationMice, Inbred C57BLBlood Group IncompatibilityMyeloablative AgonistsHematopoietic Stem CellsTissue and Organ HarvestingRats, Inbred LewPrognosisCyclophosphamideLiverProspective StudiesEnd Stage Liver DiseasePatient SelectionNeoplasm TransplantationDisease-Free SurvivalBrain DeathMelphalanLiver Failure, AcuteMultiple MyelomaT-LymphocytesCell DifferentiationLiver CirrhosisBiopsyBone Marrow CellsPrimary Graft Dysfunction